PSME3 and hepatocellular carcinoma: Moreover, In two different hepatocellular carcinoma cell lines, when PA28γ was downregulated by drug, the apoptosis rate significantly increased and the proportion of cells in the G2 phase dramatically decreased, which is found to be of potential in clinic (31).